Stablepoint Partners’s Gilead Sciences GILD Stock Holding History

Stablepoint Partners’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.91M	Sell	23,047 -174	-0.7%	-$22.9K	0.4%	84
2026 Q1	$3.24M	Sell	23,221 -1,748	-7%	-$245K	0.48%	66
2025 Q4	$3.06M	Buy	24,969 +338	+1%	+$41.1K	0.48%	66
2025 Q3	$2.73M	Sell	24,631 -1,233	-5%	-$140K	0.43%	73
2025 Q2	$2.87M	Sell	25,864 -958	-4%	-$102K	0.49%	66
2025 Q1	$3.01M	Sell	26,822 -1,403	-5%	-$145K	0.54%	64
2024 Q4	$2.61M	Buy	28,225 +377	+1%	+$33.9K	0.48%	65
2024 Q3	$2.33M	Buy	27,848 +481	+2%	+$36.7K	0.43%	75
2024 Q2	$2.13M	Buy	27,367 +3,201	+13%	+$214K	0.41%	77
2024 Q1	$1.77M	Buy	24,166 +5,730	+31%	+$441K	0.36%	86
2023 Q4	$1.49M	Buy	+18,436	New	+$1.43M	0.38%	77

Other funds holding GILD

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

CIM

Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return

CGH

Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

CNB

Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Atwood & Palmer Kansas City, Missouri $1.87B AUM 24.22% 1-Year Est. Return

COPPSERS

Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

Stablepoint Partners's GILD Position: Q2 2026 in Review

Stablepoint Partners reduced its Gilead Sciences (GILD) stake by 0.75% in Q2 2026, selling an estimated $22.9K and leaving 23,047 shares worth $2.91M. The position accounts for 0.4% of the portfolio, ranked #84.

Stablepoint Partners first reported a position in GILD in Q4 2023 and has held it in 11 quarters since. The position peaked at $3.24M in Q1 2026. 361 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Stablepoint Partners held 23,047 shares of Gilead Sciences worth $2.91M as of Q2 2026.
Stablepoint Partners sold 174 Gilead Sciences shares in Q2 2026, an estimated $22.9K.
Gilead Sciences made up 0.4% of Stablepoint Partners's portfolio in Q2 2026, its #84 holding.
Stablepoint Partners first reported a position in Gilead Sciences in Q4 2023 and has held it in 11 quarters since.
Stablepoint Partners's Gilead Sciences position peaked at $3.24M in Q1 2026.
361 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Stablepoint Partners's 13F filing for Q2 2026, filed 9 Jul 2026.